Device Trial Radar · NCT04800835
A Study to Compare the 12-month Spatz3 Adjustable Balloon With a 6-month Non Adjustable Balloon
Last checked: Nov 20, 2026Latest source record: Nov 28, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
44
Actual
Start
Feb 15, 2021
Primary completion
Jul 10, 2022
Study completion Jul 10, 2022
Sponsor
- Lead sponsor
- Spatz FGIA, IncAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 16, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare a 12-month adjustable balloon over a 6-month non-adjustable balloon with 6-month dietician follow-up. The endpoint is %TBL at 12 months.
Conditions
- Overweight and Obesity
Interventions
Gastric BalloonDevice
implantation of two types of gastric balloons. Spatz3 Adjustable balloon will be implanted for 12 months and 6-month non adjustable balloon will be implanted for 6 months
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent change in total body weight (%TBL) .Time frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Asclepiades - interna a gastroenterologie, s.r.o.
Havířov, Czechia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.